SELECT COUNTRY

VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA

ANGOLA: LATEST INTERVIEWS MORE INTERVIEWS

Shahram Tafazoli
FOUNDER AND CEO, MOTION METRICS
Motion Mertics explains how the latest technologies are being deployed in African mines.
Mining
South Africa
Zambia
DRC
Mozambique
Namibia
Niger
Nigeria
Angola
MACIG
Dr. Benedito Paulo Manuel
DIRECTOR GENERAL, SOCIEDADE MINEIRA DE CATOCA LDA
Sociedade Mineira de Catoca comments on the developments affecting Angola’s mining industry.
Mining
Angola
MACIG
Carlos Amaral
GENERAL MANAGER, ACREP ANGOLA E&P
Acrep Angola E&P analyses the difficulties of expanding in Angola during the pandemic and with lower oil prices.
Oil & Gas
Angola
Lorenzo Fiorillo
EVP WEST AFRICA, ENI
ENI updates GBR on the progress of its operations across Sub-Saharan Africa.
Oil & Gas
Ghana
Mozambique
Nigeria
Angola
Republic of Congo

ANGOLA: LATEST ARTICLES

Mining
Angola
MACIG

Mining in Angola

February 26, 2020
THE OFFICIAL MINING IN AFRICA COUNTRY INVESTMENT GUIDE (MACIG) 2020
Reforms and privatizations open the door for private-sector investment as Angola looks to diversify its dependency on oil and diamonds.
Mining
Botswana
Zimbabwe
Zambia
DRC
Cote d’Ivoire
Senegal
Ghana
Burkina Faso
Angola
MACIG

The Geographic Spread of Africa’s Mining Investors

April 26, 2019
THE OFFICIAL MINING IN AFRICA COUNTRY INVESTMENT GUIDE (MACIG) 2019
International investors demonstrate reinvigorated appetite for Africa’s mining prospects – from traditional partners like the Australians to a growing Chinese and Russian presence.
MORE ARTICLES

ANGOLA: RECENTLY RELEASED PUBLICATIONS

West Africa, Copperbelt and Angola Mining 2021 E&MJ Release

March 05, 2021

MACIG Copperbelt & Angola 2021

January 27, 2021

Africa Oil & Gas 2020

October 06, 2020

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2023

In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL